Why It Matters

STATS ChipPAC Inc. is fighting for regulatory clarity as a China-owned subsidiary facing heightened scrutiny in an aggressive Congressional push to restrict advanced chip exports to China. The semiconductor assembly and testing firm is lobbying the Commerce Department on 15 CFR 748.16(a) amid reshoring incentives that favor domestic competitors and BIS systematically tightening controls on foreign-owned semiconductor service providers. Recent Congressional hearings on export control loopholes and bills like the STRIDE Act—which explicitly targets "assembly and packaging tools"—threaten regulations STATS ChipPAC depends on while domestic competitors benefit from CHIPS Act funding.

By the Numbers

STATS ChipPAC Inc. spent $58,250 in the third quarter of 2025 on its inaugural federal lobbying effort. William K.C. Ting leads the in-house effort, bringing private-sector experience from technology firms including Kyocera AVX Components Corp. and Nantero Inc. Unlike competitors such as Teradyne Inc. ($170,000 in Q3 lobbying), STATS ChipPAC chose in-house representation. The company focuses narrowly on export control regulations—specifically 15 CFR 748.16(a)—rather than the broader semiconductor policy agenda pursued by TSMC Arizona Corp. and other competitors.

The Agenda

STATS ChipPAC Inc. is lobbying the Commerce Department’s Bureau of Industry and Security on 15 CFR 748.16(a) of the Export Administration Regulations. This inaugural federal lobbying effort comes as Congress advances legislation to restrict advanced semiconductor exports to China while reshoring domestic manufacturing. Recent House Foreign Affairs Subcommittee hearings examined export control loopholes in semiconductor equipment—directly targeting STATS ChipPAC’s supply chain segment. Multiple Congressional bills could reshape the regulatory environment, including the STRIDE Act, which covers "assembly and packaging tools," and the Chip EQUIP Act, restricting CHIPS Act recipients from purchasing equipment from foreign entities of concern.

Broader Context

Congress is tightening semiconductor export controls while reshoring advanced packaging capabilities domestically. The House Foreign Affairs Subcommittee’s November 2025 hearing on "Export Control Loopholes" directly examined vulnerabilities in regulations governing STATS ChipPAC’s core business. The Biden Administration’s December 2024 controls restricted outsourced assembly services to China, but the Trump Administration rescinded those rules in May 2025. Arizona and New York are becoming federal focal points for domestic advanced packaging manufacturing, creating competitive threats to foreign-owned providers. As JCET Group’s subsidiary, STATS ChipPAC faces structural challenges as BIS systematically restricts Chinese firms’ semiconductor access.

Between The Lines

Congressional pressure intensifies with direct implications for STATS ChipPAC. The November hearing on "Export Control Loopholes" scrutinized regulations the company is lobbying on, while bills like the STRIDE Act and Chip EQUIP Act target assembly and testing services. Senators Kelly and Schumer champion federal funding for reshoring packaging capabilities, creating competitive threats for foreign-owned providers. The regulatory environment remains volatile, with the Trump Administration both tightening and loosening controls depending on technology involved.

Competitive Landscape

STATS ChipPAC enters a crowded lobbying space. Teradyne Inc. spent $170,000 in Q3 2025 lobbying on identical export control regulations. TSMC Arizona Corp. extensively lobbied on export controls and CHIPS Act implementation. KLA Corp., ASM America Inc., and Marvell Technology Inc. similarly advocate on semiconductor export controls, demonstrating industry-wide efforts to influence regulatory scope during significant volatility.

The Bottom Line

STATS ChipPAC Inc. launched its first federal lobbying effort in the third quarter spending $58,250 to address export control regulations amid Congressional pressure to tighten China restrictions while reshoring domestic manufacturing. The China-owned subsidiary faces particular complexity navigating volatile regulations that directly threaten its business model, joining competitors like Teradyne and TSMC Arizona actively lobbying on export control policy.

Access the Legis1 platform for comprehensive political news, data, and insights.

Spot something wrong? Report an issue with this article